Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK
Diamox SR 250mg Prolonged-release Capsules.
| Pharmaceutical Form |
|---|
|
Prolonged-release capsule. Orange spherical pellets contained in a size ‘1’ capsule with clear body and opaque orange cap. ‘GS 250’ is printed on the orange cap in black text. |
Each capsule contains 250 mg acetazolamide.
Excipient(s): For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetazolamide |
Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma. |
| List of Excipients |
|---|
|
Film coated Pellets: Microcrystalline Cellulose, sodium Lauryl sulphate, purified water, ethylcellulose, Hydroxypropylmethyl cellulose (E464), mineral oil light and Pigment Blend PB-230005 Orange [hydroxyl propyl cellulose, titanium dioxide and FD&C Yellow #6/Sunset yellow FCF aluminium lake (15–18% grade), Talc and FD&C Yellow #6/Sunset yellow FCF aluminium lake (38–42% grade)]. Capsules shells: Gelatine, titanium dioxide (E171), yellow iron oxide (E172) erythrosine (E127). |
Blister Packs: 28 and 30 Capsules/ Pack
Opaque UPVC/PVDC blister Pack heat sealed with aluminium foil backing in an outer carton
Not all pack sizes may be marketed.
Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0145
22 June 2004
| Drug | Countries | |
|---|---|---|
| DIAMOX | Austria, Australia, Brazil, Estonia, France, Croatia, Ireland, Japan, Netherlands, New Zealand, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
